We’ve reached a milestone worth celebrating: the official opening of our expanded AMS laboratory. Surrounded by clients, partners, colleagues and key organizations, we marked this moment with pride and dedication. A special thank you to Mayor Peter Heijkoop of Leiden for performing the opening ceremony and sharing in this exciting step forward.
This milestone represents the successful relocation of our third Accelerator Mass Spectrometer (AMS). With our well-equipped AMS facility and an experienced and driven team, we’re ready to support your upcoming mass balance, absolute bioavailability, and metabolite profiling/identification studies. By generating early hADME data, we help accelerate and de-risk clinical development.
Thank you to everyone who joined us, supported us and helped make this day truly memorable!
Rapidemic has received a $2.7 million grant from the Bill & Melinda Gates Foundation to advance its rapid, electricity-free test for chlamydia and gonorrhea. The portable test delivers results in under 15 minutes, aiming to improve STI diagnostics in low-resource settings worldwide.
The Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 development. This...
The Life Sciences Café returned after the summer break with an evening full of fresh ideas, inspiring talks, and new connections. From biomarker wearables to mental health lighting and gamified science, the community came together to explore the future of biotech innovation.